Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 8OPN | P03069 | Human Coronavirus HKU1 spike glycoprotein in complex with an alpha2,8-linked 9-O-acetylated disialoside (1-up state) | |
| 8OPN | E0YJ44 | Human Coronavirus HKU1 spike glycoprotein in complex with an alpha2,8-linked 9-O-acetylated disialoside (1-up state) | |
| 8OPO | P03069 | Human Coronavirus HKU1 spike glycoprotein in complex with an alpha2,8-linked 9-O-acetylated disialoside (3-up state) | |
| 8OPO | E0YJ44 | Human Coronavirus HKU1 spike glycoprotein in complex with an alpha2,8-linked 9-O-acetylated disialoside (3-up state) | |
| 8OPM | P03069 | Human Coronavirus HKU1 spike glycoprotein in complex with an alpha2,8-linked 9-O-acetylated disialoside (closed state) | |
| 8OPM | E0YJ44 | Human Coronavirus HKU1 spike glycoprotein in complex with an alpha2,8-linked 9-O-acetylated disialoside (closed state) | |
| 3T3Z | P05181 | Human Cytochrome P450 2E1 in complex with pilocarpine | |
| 5MVX | Q9NR61 | Human DLL4 C2-EGF3 | |
| 4CDC | P53634 | Human DPP1 in complex with (2S)-2-amino-N-((1S)-1-cyano-2-(4- phenylphenyl)ethyl)butanamide | |
| 4CDD | P53634 | Human DPP1 in complex with (2S)-N-((1S)-1-cyano-2-(4-(4-cyanophenyl) phenyl)ethyl)piperidine-2-carboxamide | |
| 4CDF | P53634 | Human DPP1 in complex with (2S,4S)-N-((1S)-1-cyano-2-(4-(4- cyanophenyl)phenyl)ethyl)-4-hydroxy-piperidine-2-carboxamide | |
| 4CDE | P53634 | Human DPP1 in complex with 4-amino-N-((1S)-1-cyano-2-(4-(4- cyanophenyl)phenyl)ethyl)tetrahydropyran-4-carboxamide | |
| 5T4B | P27487 | Human DPP4 in complex with a ligand 34a | |
| 5ISM | P27487 | Human DPP4 in complex with a novel 5,5,6-tricyclic pyrrolidine inhibitor | Dipeptidyl peptidase 4 (E.C.3.4.14.5) |
| 5I7U | P27487 | Human DPP4 in complex with a novel tricyclic hetero-cycle inhibitor | |
| 5T4E | P27487 | Human DPP4 in complex with ligand 19a | |
| 5T4H | P27487 | Human DPP4 in complex with ligand 34n | |
| 5T4F | P27487 | Human DPP4 in complex with ligand 34p | |
| 2QOE | P27487 | Human Dipeptidyl Peptidase IV in complex with a Triazolopiperazine-based beta amino acid Inhibitor | |
| 1N1M | P27487 | Human Dipeptidyl Peptidase IV/CD26 in complex with an inhibitor | Dipeptidyl Peptidase IV (E.C.3.4.14.5) |
| 1TKR | P27487 | Human Dipeptidyl Peptidase IV/CD26 inhibited with Diisopropyl FluoroPhosphate | Dipeptidyl peptidase IV (E.C.3.4.14.5) |
| 2JID | P27487 | Human Dipeptidyl peptidase IV in complex with 1-(3,4-Dimethoxy-phenyl) -3-m-tolyl-piperidine-4-ylamine | DIPEPTIDYL PEPTIDASE 4 (E.C.3.4.14.5) |
| 1RWQ | P27487 | Human Dipeptidyl peptidase IV in complex with 5-aminomethyl-6-(2,4-dichloro-phenyl)-2-(3,5-dimethoxy-phenyl)-pyrimidin-4-ylamine | Dipeptidyl peptidase IV (E.C.3.4.14.5) |
| 6M8P | Q9NZ08 | Human ERAP1 bound to phosphinic pseudotripeptide inhibitor DG013 | |
| 8D0U | Q9Y231 | Human FUT9 bound to GDP | |
| 8D0R | Q9Y231 | Human FUT9 bound to GDP and H-Type 2 | |
| 8D0S | Q9Y231 | Human FUT9 bound to GDP and LNnT | |
| 8D0Q | Q9Y231 | Human FUT9 bound to GDP-CF3-Fucose and H-Type 2 | |
| 8D0W | Q9Y231 | Human FUT9 bound to H-Type 2 | |
| 8D0X | Q9Y231 | Human FUT9 bound to LNnT | |
| 8D0P | Q9Y231 | Human FUT9, unliganded | |
| 2ZZU | P08709 | Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-aminobenzamidine | |
| 2ZZU | P13726 | Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-aminobenzamidine | |
| 1WV7 | P08709 | Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamidine | Coagulation factor VII (E.C.3.4.21.21), Tissue factor |
| 1WV7 | P13726 | Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamidine | Coagulation factor VII (E.C.3.4.21.21), Tissue factor |
| 1WUN | P08709 | Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine | |
| 1WUN | P13726 | Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine | |
| 1WTG | P08709 | Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzamidine | |
| 1WTG | P13726 | Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzamidine | |
| 1WQV | P08709 | Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine | |
| 1WQV | P13726 | Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine | |
| 1WSS | P08709 | Human Factor Viia-Tissue Factor in Complex with peptide-mimetic inhibitor that has two charged groups in P2 and P4 | |
| 1WSS | P13726 | Human Factor Viia-Tissue Factor in Complex with peptide-mimetic inhibitor that has two charged groups in P2 and P4 | |
| 7CVH | P09467 | Human Fructose-1,6-bisphosphatase 1 in complex with geranylgeranyl diphosphate | |
| 6D6U | P47870 | Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation A | |
| 6D6U | P14867 | Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation A | |
| 6D6U | P18507 | Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation A | |
| 6D6U | 6D6U | Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation A | |
| 6D6T | P47870 | Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation B | |
| 6D6T | P14867 | Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation B |
